Rights and permissions
About this article
Cite this article
Biomarker testing in NSCLC patients worthwhile in the US?. Pharmacoecon. Outcomes News 650, 3 (2012). https://doi.org/10.2165/00151234-201206500-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206500-00008